Tilray | TRLY - Des Atouts

Prix De L'Action
9.12
Variation Quotidienne
-0.15 -1.62%
Mensuellement
-14.29%
Annuel
891.30%
Q1 Prévisions
9.24




Des Atouts Changement Date
Acasti Pharma USD 66.58M 3.22M 2025-09
Akebia Therapeutics USD 376.56M 12.41M 2025-12
Alaunos Therapeutics USD 3.72M 1.01M 2025-09
Aurora Cannabis CAD 775.29M 18.43M 2025-12
Avita Medical AUD 56.39M 1.74M 2025-12
Canopy Growth CAD 1.11B 36.35M 2025-12
Cronos Group USD 1.2B 18.73M 2025-12
Dianthus Therapeutics USD 530.92M 46.52M 2025-12
Divis Laboratories Ltd INR 181.51B 12.19B 2025-09
Ionis Pharmaceuticals USD 3.52B 490.91M 2025-12
IQVIA Holdings USD 29.94B 1.22B 2025-12
Knight Therapeutics CAD 1.05B 2.28M 2025-12
Moderna USD 12.34B 203M 2025-12
Organigram Holdings CAD 530.67M 31.54M 2025-12
Organon & Co USD 13.55B 52M 2025-09
Revvity USD 12.17B 29.46M 2025-12
Tectonic Therapeutic USD 261.04M 15.96M 2025-12
Tilray USD 2.1B 15.95M 2025-09
Viatris USD 37.19B 727.3M 2025-12
Xeris Pharmaceuticals USD 383.53M 13.34M 2025-12
Zealand Pharma A/S 15.95B 848.45M 2025-12